Does Medical Cannabis Reduce Dystonia-Related Tremors or Spasms? 

Current research suggests that medical cannabis may help reduce dystonia-related tremors and muscle spasms, particularly when standard treatments do not provide enough relief. 
However, scientific proof is still limited, and NHS and NICE do not currently recommend its use for dystonia. 

What Patients and Studies Report 

A 2023 study published in Frontiers in Neurology followed 23 people with dystonia using prescribed medical cannabis for over two years. Patients with generalised or multifocal dystonia reported up to 63% improvement in spasms, pain, and rigidity. 

THC-dominant products were linked with greater symptom relief than CBD-based oils. Most participants described milder side effects such as dry mouth, fatigue, or dizziness. 

Another 2023 analysis, Hidding et al., noted individual improvements in tremor control with high-dose CBD (up to 600 mg daily), though the evidence remained anecdotal and uncontrolled. 

Findings from Parkinson’s-related dystonia cohorts also suggest combined THC:CBD tinctures may ease muscle tightness and spasticity (PubMed 37191563). 

How Cannabinoids Might Reduce Tremors 

THC activates CB1 receptors in the brain’s movement-control areas, such as the basal ganglia and substantia nigra, which may help calm excessive nerve firing and reduce muscle spasms. 

CBD works differently. It may stabilise mood, reduce inflammation, and regulate endocannabinoid tone, which could indirectly lessen tremor frequency or intensity. 

Experts note that the best THC-to-CBD ratio and dose remain uncertain, and too much THC can sometimes cause sedation or worsen motor slowing. 

What UK Guidance Says 

According to NHS guidance and NICE Guidance NG144, medical cannabis is only approved for MS-related spasticity, severe epilepsy, and chemotherapy-induced nausea. Dystonia is not an approved indication. 

Cannabis-based products for dystonia are unlicensed and can be prescribed only by a specialist doctor as a “special” medicine under UK regulation 167. Most access occurs privately, not through the NHS. 

Key Clinical Insights 

• Small studies show potential benefits in tremor and spasm reduction. 

• THC-dominant formulations appear more effective than CBD alone. 

• No randomised controlled trials confirm benefit yet. 

• NICE and NHS continue to advise caution pending stronger evidence 

Safe Next Steps 

Providers like AlleviMed can help patients understand eligibility and safe access pathways for medical cannabis under UK law. 

Anyone considering this treatment should consult a specialist neurologist experienced in cannabis-based medicines to ensure that any use is legal, safe, and clinically supervised. 

Takeaway 

Early findings suggest that medical cannabis, particularly THC-rich formulations, may ease tremors or spasms in some people with dystonia, but proof remains limited. According to NHS and NICE guidance, such treatments should only be tried under specialist medical care and viewed as experimental rather than routine therapy.